Beta Bionics Ratios (2023-2025) | BBNX

Ratios Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 55.68%53.73%53.36%57.19%50.86%53.80%55.48%
EBT Margin -64.29%-71.72%-60.77%-59.13%-91.88%-72.58%-52.14%
EBIT Margin -73.09%-78.32%-65.71%-63.78%-105.69%-85.52%-62.54%
EBITDA Margin -97.28%-96.30%-57.81%-88.56%-161.47%-72.98%-51.39%
Operating Margin -73.09%-78.32%-65.71%-63.78%-105.69%-85.52%-62.54%
Net Margin -64.29%-71.72%-60.77%-59.13%-91.88%-72.58%-52.14%
FCF Margin -97.04%-84.99%-68.79%-72.60%-117.21%-64.58%-36.73%
Efficiency
Inventory Average 14.53M16.53M18.85M
Assets Average 243.83M334.00M330.01M
Equity Average -208.71M-217.77M-225.03M-237.10M34.20M307.69M298.20M
Invested Capital -203.10M-214.32M-221.21M-228.85M-245.36M313.75M301.63M294.76M
Asset Utilization Ratio 0.290.230.27
Leverage & Solvency
Equity Ratio -1.85-1.640.930.910.89
Valuation
Enterprise Value -96.75M-22.07M-13.03M-17.48M-103.58M-231.47M-249.72M-228.69M
Return Ratios
Return on Sales -0.64%-0.72%-0.61%-0.59%-0.92%-0.73%-0.52%
Return on Capital Employed -0.24%-0.20%-0.23%
Return on Assets -0.20%-0.17%-0.18%
Return on Equity 0.13%0.17%-1.44%-0.18%-0.20%